Skip to main content
SpringerLink
Log in

Psoriasis and Dry Skin: The Impact of Moisturizers

  • Chapter
  • First Online:
Treatment of Dry Skin Syndrome

Abstract

In the dawn of twenty-first century, psoriasis is considered a chronic, systemic, inflammatory disease that affects skin and its appendages. Dermatology has entered the era of specific systemic treatments with biological therapeutic agents. On the other hand, emollients and moisturizers are still essential in the topical adjuvant treatment of psoriasis not only in the remission phase. They are excellent supplements to the classical and novel treatments and help to reduce the scale load of the individual patient. Their major role is to support the normalizing of hyperproliferation, differentiation and apoptosis. In addition, they exert anti-inflammatory effects, e.g. through physiological lipids. The improvement of epidermal barrier function and stratum corneum hydration makes the skin resistant to external stressors, causing the Köbner phenomenon in psoriasis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Seite S, Khemis A, Rougier A et al (2009) Emollient for maintenance therapy after topical corticotherapy in mild psoriasis. Exp Dermatol 18:1076–1078

    Article  PubMed  CAS  Google Scholar 

  2. Murphy G, Reich K (2011) In touch with psoriasis: topical treatments and current guidelines. J Eur Acad Dermatol Venereol 25(Suppl 4):3–8

    Article  PubMed  CAS  Google Scholar 

  3. Christopheres E, Mrowietz U (2003) Psoriasis. In: Freedberg IR, Eisen AZ, Wolff K et al (eds) Fitzpatrick’s dermatology in general medicine, McGraw-Hill Professional, New York City, USA, vol, 6th edn, pp 407–427

    Google Scholar 

  4. Zeichner JA, Lebwohl MG, Menter A et al (2010) Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis 86:5–31; quiz 2

    PubMed  Google Scholar 

  5. Guttman-Yassky E, Krueger JG (2007) Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research. Br J Dermatol 157:1103–1115

    Article  PubMed  CAS  Google Scholar 

  6. Wippel-Slupetzky K, Stingl G (2009) Future perspectives in the treatment of psoriasis. Curr Probl Dermatol 38:172–189

    Article  PubMed  CAS  Google Scholar 

  7. Witman PM (2001) Topical therapies for localized psoriasis. Mayo Clin Proc 76:943–949

    PubMed  CAS  Google Scholar 

  8. Garcia-Valladares I, Cuchacovich R, Espinoza LR (2011) Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab. Drug Des Devel Ther 5:41–49

    PubMed  CAS  Google Scholar 

  9. Greaves MW, Weinstein GD (1995) Treatment of psoriasis. N Engl J Med 332:581–588

    Article  PubMed  CAS  Google Scholar 

  10. Schopf E, Mueller JM, Ostermann T (1995) Value of adjuvant basic therapy in chronic recurrent skin diseases. Neurodermatitis atopica/psoriasis vulgaris. Hautarzt 46:451–454

    Article  PubMed  CAS  Google Scholar 

  11. Bikowski J (2001) The use of therapeutic moisturizers in various dermatologic disorders. Cutis 68:3–11

    PubMed  CAS  Google Scholar 

  12. Brubacher JR, Hoffman RS (1996) Salicylism from topical salicylates: review of the literature. J Toxicol Clin Toxicol 34:431–436

    Article  PubMed  CAS  Google Scholar 

  13. Nola I, Kostovic K, Kotrulja L et al (2003) The use of emollients as sophisticated therapy in dermatology. Acta Dermatovenerol Croat 11:80–87

    PubMed  Google Scholar 

  14. Meyer N, Paul C, Feneron D et al (2010) Psoriasis: an epidemiological evaluation of disease burden in 590 patients. J Eur Acad Dermatol Venereol 24:1075–1082

    PubMed  CAS  Google Scholar 

  15. Watsky KL, Freije L, Leneveu MC et al (1992) Water-in-oil emollients as steroid-sparing adjunctive therapy in the treatment of psoriasis. Cutis 50:383–386

    PubMed  CAS  Google Scholar 

  16. Menter A, Korman NJ, Elmets CA et al (2009) Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol 60:643–659

    Article  PubMed  Google Scholar 

  17. Comaish JS, Greener JS (1976) The inhibiting effect of soft paraffin on the Kobner response in psoriasis. Br J Dermatol 94:195–200

    Article  PubMed  CAS  Google Scholar 

  18. Finlay AY (1997) Emollients as adjuvant therapy for psoriasis. J Dermatolog Treat 8(Suppl 1):S25–S27

    Article  Google Scholar 

  19. Cassano N, Mantegazza R, Battaglini S et al (2010) Adjuvant role of a new emollient cream in patients with palmar and/or plantar psoriasis: a pilot randomized open-label study. G Ital Dermatol Venereol 145:789–792

    PubMed  CAS  Google Scholar 

  20. Tanghetti EA (2000) An observation study evaluating the treatment of plaque psoriasis with tazarotene gels, alone and with an emollient and/or corticosteroid. Cutis 66:4–11

    PubMed  CAS  Google Scholar 

  21. Syed TA, Ahmad SA, Holt AH et al (1996) Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study. Trop Med Int Health 1:505–509

    Article  PubMed  CAS  Google Scholar 

  22. Paulsen E, Korsholm L, Brandrup F (2005) A double-blind, placebo-controlled study of a commercial Aloe vera gel in the treatment of slight to moderate psoriasis vulgaris. J Eur Acad Dermatol Venereol 19:326–331

    Article  PubMed  CAS  Google Scholar 

  23. Held E, Sveinsdottir S, Agner T (1999) Effect of long-term use of moisturizer on skin hydration, barrier function and susceptibility to irritants. Acta Derm Venereol 79:49–51

    Article  PubMed  CAS  Google Scholar 

  24. Gloor M, Hauth A, Gehring W (2003) O/W emulsions compromise the stratum corneum barrier and improve drug penetration. Pharmazie 58:709–715

    PubMed  CAS  Google Scholar 

  25. Fluhr JW, Gloor M, Bettinger J et al (1998) On the influence of bath oils with different solvent characteristics and different amounts of a non-ionic tenside on the hydration and barrier function of the stratum corneum. J Cosmet Sci 49:343–350

    CAS  Google Scholar 

  26. Rim JH, Jo SJ, Park JY et al (2005) Electrical measurement of moisturizing effect on skin hydration and barrier function in psoriasis patients. Clin Exp Dermatol 30:409–413

    Article  PubMed  CAS  Google Scholar 

  27. van Duijnhoven MW, Hagenberg R, Pasch MC et al (2005) Novel quantitative immunofluorescent technique reveals improvements in epidermal cell populations after mild treatment of psoriasis. Acta Derm Venereol 85:311–317

    PubMed  Google Scholar 

  28. Penven K, Leroy D, Verneuil L et al (2005) Evaluation of Vaseline oil applied prior to UVB TL01 phototherapy in the treatment of psoriasis. Photodermatol Photoimmunol Photomed 21:138–141

    Article  PubMed  CAS  Google Scholar 

  29. Birgin B, Fetil E, Ilknur T et al (2005) Effects of topical petrolatum and salicylic acid upon skin photoreaction to UVA. Eur J Dermatol 15:156–158

    PubMed  Google Scholar 

  30. Fetil E, Ozka S, Soyal MC et al (2002) Effects of topical petrolatum and salicylic acid on the erythemogenicity of UVB. Eur J Dermatol 12:154–156

    PubMed  CAS  Google Scholar 

  31. Draelos ZD (2008) Moisturizing cream ameliorates dryness and desquamation in participants not receiving topical psoriasis treatment. Cutis 82:211–216

    PubMed  Google Scholar 

  32. Lebwohl M (1999) The role of salicylic acid in the treatment of psoriasis. Int J Dermatol 38:16–24

    Article  PubMed  CAS  Google Scholar 

  33. Moncorps C (1929) Untersuchungen über die Pharmakologie und Pharmakodynamik von Salben und salbeninkorporierten Medikamenten II. Mitteilung: Über die Resorption und Pharmakodynamik der salbeninkorporiereten Salizylsäure. Arch Exp Path Pharm 155 (1–2): 51–69

    Google Scholar 

  34. Arnold W, Trinnes F, Schroeder I (1979) Skin resorption of salicylic acid in psoriasis patients and persons with healthy skin. Beitr Gerichtl Med 37:325–328

    PubMed  CAS  Google Scholar 

  35. Gabard B, Treffel P, Schwarb F, Surber C, Bieli E, Lüdi S (1997) Salicylic acid release from topical formulations does not predict in vitro skin absorption. Dermatology 195:37–43

    Google Scholar 

  36. Schwarb F, Gabard B, Jost G, Rufli Th, Surber C (1997) Percutaneous absorption of salicylic acid in man following topical administration of different formulations. Dermatology 195

    Google Scholar 

  37. Weirich EG, Longauer JK, Kirkwood AH (1978) Effect of topical salicylic acid on animal epidermopoiesis. Dermatologica 156:89–96

    Article  PubMed  CAS  Google Scholar 

  38. Pullmann H, Lennartz KJ, Steigleder GK (1975) The effect of salicylic acid on epidermal cell proliferation kinetics in psoriasis. Autoradiographic in vitro-investigations(author’s transl). Arch Dermatol Forsch 251:271–275

    Article  PubMed  CAS  Google Scholar 

  39. Roberts DL, Marshall R, Marks R (1980) Detection of the action of salicylic acid on the normal stratum corneum. Br J Dermatol 103:191–196

    Article  PubMed  CAS  Google Scholar 

  40. Davies M, Marks R (1976) Studies on the effect of salicylic acid on normal skin. Br J Dermatol 95:187–192

    Article  PubMed  CAS  Google Scholar 

  41. Huber C, Christophers E (1977) “Keratolytic” effect of salicylic acid. Arch Dermatol Res 257:293–297

    Article  PubMed  CAS  Google Scholar 

  42. Nook TH (1987) In vivo measurement of the keratolytic effect of salicylic acid in three ointment formulations. Br J Dermatol 117:243–245

    Article  PubMed  CAS  Google Scholar 

  43. Gloor M, Beier B (1984) Keratoplastic effect of salicyclic acid, sulfur and a tensio-active mixture. Z Hautkr 59:1657–1660

    PubMed  CAS  Google Scholar 

  44. Going SM, Guyer BM, Jarvie DR et al (1986) Salicylic acid gel for scalp psoriasis. Clin Exp Dermatol 11:260–262

    Article  PubMed  CAS  Google Scholar 

  45. Hulsebosch HJ, Ponec-Waelsch M (1972) The interaction of anthralin, salicylic acid and zinc oxide in pastes. Dermatologica 144:287–293

    Article  PubMed  CAS  Google Scholar 

  46. Runne U (1974) Anthralin-salicylic acid therapy of psoriasis. Cignolin-salicylic acid-vaseline treatment and Lasan paste in a right-left comparison. Hautarzt 25:199–200

    PubMed  CAS  Google Scholar 

  47. Diem E, Fritsch P (1973) Salicylate poisoning by percutaneous resorption. Hautarzt 24:552–555

    PubMed  CAS  Google Scholar 

  48. Zesch A (1986) Short and long-term risks of topical drugs. Br J Dermatol 115(Suppl 31):63–70

    Article  PubMed  Google Scholar 

  49. Chapman BJ, Proudfoot AT (1989) Adult salicylate poisoning: deaths and outcome in patients with high plasma salicylate concentrations. Q J Med 72:699–707

    PubMed  CAS  Google Scholar 

  50. Pec J, Strmenova M, Palencarova E et al (1992) Salicylate intoxication after use of topical salicylic acid ointment by a patient with psoriasis. Cutis 50:307–309

    PubMed  CAS  Google Scholar 

  51. Luderschmidt C, Plewig G (1975) Chronic percutaneous salicylic acid poisoning. Hautarzt 26:643–646

    PubMed  CAS  Google Scholar 

  52. Germann R, Schindera I, Kuch M et al (1996) Life threatening salicylate poisoning caused by percutaneous absorption in severe ichthyosis vulgaris. Hautarzt 47:624–627

    Article  PubMed  CAS  Google Scholar 

  53. Vonweiss JF, Lever WF (1964) Percutaneous salicylic acid intoxication in psoriasis. Arch Dermatol 90:614–619

    Article  PubMed  CAS  Google Scholar 

  54. Taylor JR, Halprin KM (1975) Percutaneous absorption of salicylic acid. Arch Dermatol 111:740–743

    Article  PubMed  CAS  Google Scholar 

  55. van de Kerkhof PC, Vissers WH (2003) The topical treatment of psoriasis. Skin Pharmacol Appl Skin Physiol 16:69–83

    Article  PubMed  Google Scholar 

  56. Waller JM, Dreher F, Behnam S et al (2006) ‘Keratolytic’ properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man. Skin Pharmacol Physiol 19:283–289

    Article  PubMed  CAS  Google Scholar 

  57. Bashir SJ, Dreher F, Chew AL et al (2005) Cutaneous bioassay of salicylic acid as a keratolytic. Int J Pharm 292:187–194

    Article  PubMed  CAS  Google Scholar 

  58. Klimowicz A, Farfal S, Bielecka-Grzela S (2007) Evaluation of skin penetration of topically applied drugs in humans by cutaneous microdialysis: acyclovir vs. salicylic acid. J Clin Pharm Ther 32:143–148

    Article  PubMed  CAS  Google Scholar 

  59. Klimowicz A, Bielecka-Grzela S, Groth L et al (2004) Use of an intraluminal guide wire in linear microdialysis probes: effect on recovery? Skin Res Technol 10:104–108

    Article  PubMed  Google Scholar 

  60. Loden M (1996) Urea-containing moisturizers influence barrier properties of normal skin. Arch Dermatol Res 288:103–107

    Article  PubMed  CAS  Google Scholar 

  61. Loden M (1997) Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream. Contact Dermatitis 36:256–260

    Article  PubMed  CAS  Google Scholar 

  62. Treffel P, Gabard B (1995) Stratum corneum dynamic function measurements after moisturizer or irritant application. Arch Dermatol Res 287:474–479

    Article  PubMed  CAS  Google Scholar 

  63. Bettinger J, Gloor M, Gehring W, Wolf W (1995) Influence of emulsions with and without urea an water-binding capacity of the stratum corneum. J Soc Cosmet Chem 46:247–254

    CAS  Google Scholar 

  64. Muller KH, Pflugshaupt C (1989) Urea in dermatology I. Hautarzt 40(Suppl 9):1–12

    Article  PubMed  Google Scholar 

  65. Wohlrab W (1988) Effect of urea on the water binding capacity of the human stratum corneum. Dermatol Monatsschr 174:622–627

    PubMed  CAS  Google Scholar 

  66. Fluhr JW, Vrzak G, Gloor M (1998) Hydratisierende und die Steroidpenetration verbessernder Effekt von Harnstoff und Glycerin in Abhänigkeit von der verwendeten Grundlage. Z Hautkr 73:55–59

    Google Scholar 

  67. Wohlrab W, Schiemann S (1976) Investigations on the mechanism of the activity of urea upon the epidermis (author’s transl). Arch Dermatol Res 255:23–30

    Article  PubMed  CAS  Google Scholar 

  68. Wohlrab W (1992) Harnstoff-ein bewährter Wirkstoff in der Dermatologie und Kosmetik. P Z 33:2483–2489

    Google Scholar 

  69. Wohlrab W (1986) Recovery rate of externally administered glucocorticoids on the skin surface. Dermatol Monatsschr 172:615–619

    PubMed  CAS  Google Scholar 

  70. Feldmann RJ, Maibach HI (1974) Percutaneous penetration of hydrocortisone with urea. Arch Dermatol 109:58–59

    Article  PubMed  CAS  Google Scholar 

  71. Wohlrab W (1984) The influence of urea on the penetration kinetics of topically applied corticosteroids. Acta Derm Venereol 64:233–238

    PubMed  CAS  Google Scholar 

  72. Stuttgen G (1989) Promoting penetration of locally applied substances by urea. Hautarzt 40(Suppl 9):27–31

    Article  PubMed  Google Scholar 

  73. Gloor M, Lindemann J (1980) The influence of ceratolytics and moisturizers on the bio-availability of triamcinolone acetonide following topical application (author’s transl). Dermatol Monatsschr 166:102–106

    PubMed  CAS  Google Scholar 

  74. Kalbitz J, Neubert R, Wohlrab W (1996) Modulation of drug penetration in the skin. Pharmazie 51:619–637

    PubMed  CAS  Google Scholar 

  75. Fluhr JW, Gloor M, Gehring W (2000) Physiology of Skin cleaning and functional mechanism of bath oils. In: Berardesca E, Picardo M, Pigatto P (eds) Irritant contact dermatitis – proceedings of the 3 rd International Symposium (ISICD). Medical Publishing & New Media, Milano, pp 291–307

    Google Scholar 

  76. Müller KH, Pflugshaupt Ch (1979) Harnstoff in der Dermatologie. Zbl Haut 1:14–15

    Google Scholar 

  77. Gabard B, Bieli E (1989) Salicylic acid and urea–possible modification of the keratolytic effect of salicylic acid by urea. Hautarzt 40(Suppl 9):71–73

    Article  PubMed  Google Scholar 

  78. Hagemann I, Proksch E (1996) Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis. Acta Derm Venereol 76:353–356

    PubMed  CAS  Google Scholar 

  79. Sasaki Y, Tadaki T, Tagami H (1989) The effects of a topical application of urea cream on the function of pathological stratum corneum. Acta Dermatol – Kyoto 84:31

    Google Scholar 

  80. Shemer A, Nathansohn N, Kaplan B et al (2000) Treatment of scalp seborrheic dermatitis and psoriasis with an ointment of 40% urea and 1% bifonazole. Int J Dermatol 39:532–534

    Article  PubMed  CAS  Google Scholar 

  81. Gloor M, Fluhr J, Wasik B et al (2001) Clinical effect of salicylic acid and high dose urea applied according to the standardized New German Formulary. Pharmazie 56:810–814

    PubMed  CAS  Google Scholar 

  82. Hardening CR, Watkinson A, Rawlings AV, Scott IR (2000) Dry skin, moisturization and corneodesmolysis. Int J Cosmet Sci 22:21–52

    Article  Google Scholar 

  83. Lynde CW (2001) Moisturizers: what they are and how they work. Skin Therapy Lett 6:3–5

    PubMed  CAS  Google Scholar 

  84. Kostarelos K, Teknetzis A, Lefaki I et al (2000) Double-blind clinical study reveals synergistic action between alpha-hydroxy acid and betamethasone lotions towards topical treatment of scalp psoriasis. J Eur Acad Dermatol Venereol 14:5–9

    Article  PubMed  CAS  Google Scholar 

  85. Berardesca E, Piero Vignoli G, Distante E (1998) Effects of glycolic acid on psoriasis. Clin Exp Dermatol 23:190–191

    Article  PubMed  CAS  Google Scholar 

  86. Escobar SO, Achenbach R, Iannantuono R et al (1992) Topical fish oil in psoriasis – a controlled and blind study. Clin Exp Dermatol 17:159–162

    Article  PubMed  CAS  Google Scholar 

  87. Dewsbury CE, Graham P, Darley CR (1989) Topical eicosapentaenoic acid (EPA) in the treatment of psoriasis. Br J Dermatol 120:581

    Article  PubMed  CAS  Google Scholar 

  88. Kragballe K, Voorhees P, Darley CR, Goetzl EJ (1985) Leukotriene B5 derived from eicosapentaenoic acid does not stimulate DNA synthesis of cultured human keratinocytes but inhibits the stimulation induced by leukotriene B4. J Invest Dermatol 84:349

    Google Scholar 

  89. Williams ML (1991) Lipids in normal and pathological desquamation. Adv Lipid Res 24:211–262

    PubMed  CAS  Google Scholar 

  90. Berardesca E, Borroni G (1998) Oral and topical supplementation of linoleic acid and skin disease. Medecine, Biologie, Environnement 26(2):159–163

    Google Scholar 

  91. Henneicke-von Zepelin HH, Mrowietz U, Farber L et al (1993) Highly purified omega-3-polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double-blind, placebo-controlled multicentre study. Br J Dermatol 129:713–717

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany

    Joachim W. Fluhr M.D.

  2. San Gallicano Dermatological Institute, Rome, Italy

    Enzo Berardesca M.D.

  3. Department of Dermatology and Venereology, Tokuda Hospital Sofia, Sofia, Bulgaria

    Razvigor Darlenski M.D., Ph.D.

Authors
  1. Joachim W. Fluhr M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Enzo Berardesca M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Razvigor Darlenski M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joachim W. Fluhr M.D. .

Editor information

Editors and Affiliations

  1. Eviderm Institute, Bergshamra Allé 9, Solna, 17077, Sweden

    Marie Lodén

  2. School of Medicine, Department Dermatology, University of California, San Francisco, Divisadero 1701, San Francisco, 94143-0989, California, USA

    Howard I. Maibach

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fluhr, J.W., Berardesca, E., Darlenski, R. (2012). Psoriasis and Dry Skin: The Impact of Moisturizers. In: Lodén, M., Maibach, H. (eds) Treatment of Dry Skin Syndrome. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27606-4_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27606-4_19

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-27605-7

  • Online ISBN: 978-3-642-27606-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation